Ola Landgren
Ola Landgren
Unknown affiliation
Verified email at
Cited by
Cited by
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
O Landgren, RA Kyle, RM Pfeiffer, JA Katzmann, NE Caporaso, RB Hayes, ...
Blood, The Journal of the American Society of Hematology 113 (22), 5412-5417, 2009
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and …
RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ...
Leukemia 24 (6), 1121-1127, 2010
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ...
Blood, The Journal of the American Society of Hematology 125 (13), 2068-2074, 2015
Solid cancers after allogeneic hematopoietic cell transplantation
JD Rizzo, RE Curtis, G Socié, KA Sobocinski, E Gilbert, O Landgren, ...
Blood, The Journal of the American Society of Hematology 113 (5), 1175-1183, 2009
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
C Blimark, E Holmberg, UH Mellqvist, O Landgren, M Björkholm, ...
haematologica 100 (1), 107, 2015
B-cell clones as early markers for chronic lymphocytic leukemia
O Landgren, M Albitar, W Ma, F Abbasi, RB Hayes, P Ghia, GE Marti, ...
New England Journal of Medicine 360 (7), 659-667, 2009
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
O Landgren, ES Gilbert, JD Rizzo, G Socié, PM Banks, KA Sobocinski, ...
Blood, The Journal of the American Society of Hematology 113 (20), 4992-5001, 2009
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus
TP Giordano, L Henderson, O Landgren, EY Chiao, JR Kramer, ...
Jama 297 (18), 2010-2017, 2007
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C Fernández de Larrea, RA Kyle, BGM Durie, H Ludwig, S Usmani, ...
Leukemia 27 (4), 780-791, 2013
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003
SY Kristinsson, O Landgren, PW Dickman, AR Derolf, M Bjorkholm
Journal of clinical oncology 25 (15), 1993-1999, 2007
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
AJ Waxman, PJ Mink, SS Devesa, WF Anderson, BM Weiss, ...
Blood, The Journal of the American Society of Hematology 116 (25), 5501-5506, 2010
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States
O Landgren, G Gridley, I Turesson, NE Caporaso, LR Goldin, D Baris, ...
Blood 107 (3), 904-906, 2006
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population‐based study of US veterans
HB El‐Serag, EA Engels, O Landgren, E Chiao, L Henderson, ...
Hepatology 49 (1), 116-123, 2009
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology
GM Dores, WF Anderson, RE Curtis, O Landgren, E Ostroumova, ...
British journal of haematology 139 (5), 809-819, 2007
Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma
N Korde, M Roschewski, A Zingone, M Kwok, EE Manasanch, M Bhutani, ...
JAMA oncology 1 (6), 746-754, 2015
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004
GM Dores, O Landgren, KA McGlynn, RE Curtis, MS Linet, SS Devesa
British journal of haematology 144 (1), 86-94, 2009
Population‐based study of autoimmune conditions and the risk of specific lymphoid malignancies
LA Anderson, S Gadalla, LM Morton, O Landgren, R Pfeiffer, JL Warren, ...
International journal of cancer 125 (2), 398-405, 2009
The system can't perform the operation now. Try again later.
Articles 1–20